Back to FI Foundations Investment Advisors, LLC
IBRX
4 quarters
Position history for FIFoundations Investment Advisors, LLC's holdings in ImmunityBio, Inc.
Yes. Foundations Investment Advisors holds 32,631 shares of IBRX (ImmunityBio), worth $308,037, as of its Q3 2026 13F filing. It increased the position by 255 shares (+0.8%) from Q2 2026. Foundations Investment Advisors has held IBRX since Q4 2025, across 4 quarterly 13F filings.
Current Value
$308,037
Current Shares
32,631
Total Value Change
+$245,039
Total Shares Change
+814
Quarter-by-Quarter History